Study examines incident hepatitis C infection in HIV-infected men

Feb 01, 2011

Hepatitis C is a leading cause of illness and death for individuals infected with both HIV and hepatitis C. Recent reports from around the world demonstrate that hepatitis C is emerging as a sexually transmitted infection among HIV-infected men who do not inject drugs. However, many HIV-infected men do not receive continued screening for hepatitis C throughout their HIV care.

Hepatitis C symptoms often do not manifest themselves until the later stages of the illness, so people are not as likely to know that they have become infected and hence need further testing and treatment. Researchers examined the role of later acquisition of hepatitis C in patients in a new study published in Clinical Infectious Diseases, which is currently available online.

In the study, 1,800 HIV-infected men had an initial negative hepatitis C blood test result, with at least one subsequent test. At the time of their initial negative hepatitis C results, 94 percent were receiving antiretroviral therapy for HIV and 6 percent reported current or prior injection drug use.

Ultimately, 36 patients were subsequently diagnosed with hepatitis C. Of those, 25 percent reported an injection drug use history, although 75 percent reported no current or previous injection drug use.

"Screening HIV-infected patients for hepatitis C only once upon entry into HIV care is not sufficient," according to study author Lynn E. Taylor, MD, of Brown University in Providence, R. I. "The standard of care needs to change. HIV-infected persons should have access to ongoing screening for hepatitis C. Doctors and patients may not be aware of or freely discuss all risk behaviors that may lead to C infection. These behaviors are often stigmatized. Patients may not feel comfortable discussing these risk factors nor may they be aware of all the ways in which may be transmitted via blood."

Explore further: Haiti cholera outbreak kills 132 in 2014

More information: http://cid.oxfordjournals.org/content/early/2011/01/29/cid.ciq201.full

add to favorites email to friend print save as pdf

Related Stories

When HIV and liver disease co-exist

Jun 01, 2007

[B]Hepatologists face new challenges as hepatitis progresses in HIV patients[/B] Since successful antiretroviral therapies have made HIV a treatable condition, more HIV patients who are also infected with hepatitis B or ...

New treatment for hepatitis C

May 14, 2008

Researchers at the University of Oklahoma Health Sciences Center have found a new use for an old drug. Their findings appear online in the American Journal of Gastroenterology.

Recommended for you

Sierra Leone to miss target for beating Ebola: UN

7 minutes ago

The United Nations' Ebola response mission admitted Thursday it was going to miss its target for beating the deadly epidemic in Sierra Leone due to a chronic shortage of hospital beds.

Global Ebola toll rises to 5,689: WHO

4 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

15 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.